Medrx Co.,Ltd.

4586・Growth Market・Pharmaceuticals

Official website

Medrx Co.,Ltd.

4586・Growth Market・Pharmaceuticals

Official website

Medrx Co.,Ltd.4586

Reference Indicators

Market Cap

36¥100M

P/E (Forecast)

—

P/B

1.8x

Dividend Yield (Forecast)

0.00%

ROE

-49.1%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	8	59	29	257	128
Cost of Sales	2	2	2	0	1
Gross Profit	6	56	27	257	126
SG&A Expenses	1,067	1,155	960	1,050	1,068
Operating Income	-1,061	-1,098	-933	-793	-941
Non-operating Income	1	1	14	52	20
Non-operating Expenses	14	14	11	15	15
Ordinary Income	-1,074	-1,112	-930	-755	-937
Extraordinary Income	15	2	0	20	12
Extraordinary Losses	—	—	—	68	—
Pre-tax Income	-1,058	-1,109	-930	-802	-925
Income Taxes	1	1	2	4	12
Net Income	-1,059	-1,111	-932	-806	-937
EBITDA	-1,000	-1,052	-888	-754	-928
Gross Margin	72.9%	95.6%	91.9%	99.9%	99.1%
Operating Margin	-12709.3%	-1847.3%	-3161.0%	-307.5%	-735.5%
ROA	-50.3%	-79.5%	-45.5%	-35.5%	-43.4%
ROE	-55.9%	-97.5%	-50.5%	-38.3%	-49.1%